We have studied the effects of 1-heptanol and nifedipine on noradrenaline (NA)-induced contractions in order to explore the role of gap junctions and their interactions with L-type Ca 2+ channel mediated [Ca 2+ ]o entry in the generation of NA-induced contractions in the rat vas deferens. Application of 20 μM NA to rat vas deferens resulted in contractions with three different components, an initial phasic component followed by a tonic component overlapped with an oscillatory component. Heptanol (0.01-2 mM) induced a concentration dependent reduction of the contractions. 2 mM heptanol reduced the phasic component by 32.9 ± 4.4% and the tonic component by 93.8 ± 1.9% of control, while the oscillatory component was completely abolished (n=7). Nifedipine (2 μM) reduced the phasic component by 34.5 ± 4.1% and the tonic component by 89.5 ± 3.8% of control and abolished the oscillatory component (n=6). In the presence of heptanol and nifedipine together, the phasic component was reduced by 61.3 ± 8.3% and the tonic component by 94.5 ± 1.0% of control. The oscillatory component was completely abolished (n=6). These results allow the conclusion that phasic contraction is mainly due to the direct action of NA, independent of gap junctions, while the tonic and oscillatory contractions may depend significantly on cell-to-cell communication. These in turn may depend critically on the availability of extracellularly derived Ca 2+ .
Introduction
thus allowing neighboring smooth muscle cells to be in electrical and functional continuity with each other (Veenstra, 1996) forming what is described as a functional syncytium (Tomita, 1967) .
However, the role of cell-to-cell coupling in determining the overall contractile response of smooth muscle is not yet fully understood. For example, in the rat vas deferens, the neurogenic contractile response to tetanic stimulation consists of two distinct phases: a rapid purinergic phase mediated by electrical activation via the excitatory junction potential (EJP), and a second slower phase brought about by action of noradrenaline (NA) via biochemical cascades (Rembold, 1996) . The role of cell-to-cell coupling in modulating the nature of the adrenergic contractions has not yet been fully explored. One approach towards addressing this question is to investigate the contraction produced by the exogenous application of NA, which precludes the involvement of presynaptic mechanisms Christ et al., 1999) .
In rat vas deferens, exogenously applied NA brings about three characteristic phases of contraction. These are the phasic, tonic, and oscillatory components (Boselli et al., 1997) . The phasic component is thought mainly to depend on intracellular Ca 2+ sources such as endoplasmic reticulum, mitochondria, etc. The tonic and oscillatory components on the other hand, are reportedly dependent on [Ca 2+ ]o . The mechanisms resulting in the generation of these three components, in particular the role of gap junctions remain to be elucidated. In the present study, we have used 1-heptanol, a relatively selective gap junction blocker in smooth muscle systems (Christ et al., 1991; Hennig et al., 2002; Huizinga et al., 1988; Manchanda and Venkateswarlu, 1997; Matchkov et al., 2004; Saez et al., 1989) , to elucidate the role of gap junctions in the NA-induced contractions.
Since gap junctions allow Ca 2+ ions to diffuse between cells for recruitment during contraction, cell-to-cell communication could powerfully determine Ca 2+ dynamics, and hence the overall contractility in syncytial tissue (Sanderson et al., 1994; Sell et al., 2002) . For example, in murine large intestine the rapid propagation of intracellular Ca 2+ waves across the longitudinal muscle layer was blocked by heptanol, while the L-type Ca 2+ channel blocker nicardipine, only reduced its frequency and intensity (Hennig et al., 2002) . 
Methods

Animals
Male Wistar rats, weighing 250-350 g, obtained from National Institute of Nutrition, Hyderabad were used in this study. The experimental procedures used in this study were approved by Animal Experimentation Ethics Committee of the Indian Institute of TechnologyBombay.
Experimental procedures
The rats were stunned and exsanguinated, and the vasa differentia were carefully removed and cleared of the surrounding connective tissue. The vas was mounted vertically in an organ bath (volume 25 ml). The prostatic end of the vas was tied to an isometric force transducer using surgical sutures and the epididymal end was affixed to the bottom of the organ bath. The tissue was continuously superfused with physiological Krebs solution (composition in mM: NaCl 118.4, KCl 4.7, MgCl2 1.2, CaCl2 2.5, NaHCO3 25.0, NaH2PO4 0.4 and glucose 11.1) equilibrated with carbogen (95% O2, 5% CO2) to maintain the pH at 7.4-7.5. The tissue was allowed to rest for 45 min in the organ bath at a resting tension of 2 mN. All the experiments were conducted at room temperature (25-30°C). The output of the strain gauge force transducer was fed to a DC amplifier (Recorders & Medicare Systems, Chandigarh, India). The signal was displayed on a digital storage oscilloscope (TDS 210, Tektronix, USA) and simultaneously digitized and recorded on a digital tape recorder (DTR-1204, Biologic, France). The data was later played back, digitized and collected on a PC using a NI AT-MIO-16XE data acquisition card and analyzed using the WCP software (courtesy Dr. J. Dempster, Stracthclyde University, Scotland).
A concentration range of 10-100 μM NA is widely used to study adrenergic mechanisms in the literature (Ashoori and Tomita, 1983; . From our own pilot studies, 20 μM NA was observed to be adequate for the development of all three reported components, without being too high in terms of the recovery of the tissue after washout, a problem encountered with higher concentrations. For these reasons we chose 20 μM NA to elicit contractions in the vas deferens. The total volume of NA stock solution added to the organ bath was less than 20 μl. NA was directly added to the organ bath and it was left in contact with the tissue for 2 min before washing out. Flow was stopped before addition of NA and during the recording of the force generated (2 min). The tissue was allowed to rest for 30 min between successive stimulations. For every experiment the heptanol solution was freshly prepared in Krebs and was introduced to the bath by replacing the normal Krebs in the organ bath.
Previous studies have shown that heptanol inhibited the EJP's of the vas deferens within a contact period of 4 min (Manchanda and Venkateswarlu, 1997) ; the same contact time was used here. Contact time for nifedipine was fixed at 40 min based on pilot studies. Stock solutions of nifedipine were prepared in DMSO. All experiments with nifedipine were conducted in semidark conditions. The combined effect of nifedipine (2 μM) and heptanol (2 mM) was also studied. As the contact times required for these two agents to elicit an effect were different, and because the response of the tissue to heptanol for a contact time of 4 min was found to be optimal, the following procedure was used. The rat vas deferens was first incubated in 2 μM nifedipine solution for 35 min, after which the solution was replaced with a solution containing nifedipine (2 μM) and heptanol (2 mM) within a minute and incubated for 4 min. The tissue was then stimulated by addition of NA to the organ bath for 2 min.
Materials
NA (Arterenol Bitartarate) and nifedipine were obtained from Sigma-Aldrich, Mumbai, India. Suramin was obtained from Tocris-Cookson Ltd., UK. Stock solution for NA was prepared in 100 mM ascorbic acid solution. Salts used for the Krebs were obtained from S.D.
Fine Chemicals Ltd., Mumbai, India.
Statistics
Student t-test, unpaired was used to study the significance of difference between set of results. The variation in the mean was calculated with the standard deviation.
Results
Application of exogenous NA (20 μM) to the vas deferens resulted in contractions consisting of a rapid initial component followed by a slower, larger component (4.0 ± 0.5 times the amplitude of the initial rapid component, (n=7)) with rhythmic contractions overlaid on this larger component. We refer to the first rapid component as the phasic component; the second larger component as the tonic component and the rhythmic contractions as the oscillatory component (Boselli et al., 1997) . The amplitude of the tonic component was measured as the height between the resting tension and the base of the overlying oscillations, as shown in Fig.  1a . The average peak-to-peak value of the spikes in the oscillatory component was taken as the height of the oscillatory component. The maximum amplitude of the oscillatory component was 12% of the tonic component in control contractions (n=7). Adrenergic contractions have been shown to induce release of adenosine 5'-triphosphate (ATP) from the non-neuronal, muscular sites (Katsuragi et al., 1991) . This released ATP could activate post-junctional purinergic P2X receptors to induce contractions. To eliminate the possibility of a contribution from this nonneuronally released ATP, the effect of suramin (300 μM) on the NA-induced contractions was also studied. The presence of suramin did not alter the contractile response to exogenously added NA (Bültmann and Starke, 2001 ), thus ruling out the possible contribution of ATP in the NA-induced contractions.
Heptanol affected NA-induced contractions over a concentration range of 0.01 mM-2 mM (see Fig. 1 ). At 0.01 mM, the effect was just observable and at 2 mM the effect on all three components of the NA-induced contraction was maximal. These effects were completely reversible after washout. The effect of heptanol on the tonic component was found to be dosedependent; however its effect on the phasic and the oscillatory components was more complex. These are elaborated below.
Effect of heptanol on the phasic component
The phasic component of the NA-induced contraction was inhibited by the presence of heptanol at the higher range of concentrations used (0.9 mM-2 mM) ( Figs. 1 and 2 ). Unlike the tonic and the oscillatory components, this phase remained resistant to heptanol even at a concentration of 2 mM. In the presence of 2 mM heptanol the amplitude of the phasic component was reduced maximally by 32.9 ± 4.4% of control (n=7) (Fig. 2) . Surprisingly, at lower concentrations (0.05 mM-0.6 mM) heptanol enhanced the phasic component significantly (129.7 ± 17.8% of control at 0.1 mM; n=7) as compared to control (P<0.01) (Fig. 2) . The latency of this phase remained unchanged during these amplitude changes.
Effect of heptanol on the tonic component
The tonic component of the NA-induced contractions was monotonically inhibited by increasing dose of heptanol (Fig. 2) . The effect of heptanol on the tonic phase of contraction was observed at concentrations ≥ 0.3 mM (37.4 ± 12.6% reduction; n=7). With 1.5 mM heptanol, the tonic component was almost completely abolished (91.4 ± 2.7% reduction; n=7; Figs. 1 and 2). In addition, development of the tonic component was progressively delayed at larger concentrations of heptanol (Fig. 3) . In the absence of heptanol a steady-state was achieved within 90 s, whereas in its presence (≥ 0.6 mM) force continued to increase until the end of the observation period (120 s). 
Effect of heptanol on the oscillatory component
At concentrations above 1.2 mM, heptanol abolished the oscillatory component of the NAinduced contraction. A significant increase in the amplitude of oscillatory contractions was observed in the presence of heptanol at concentrations below 0.9 mM (0.05 mM, 0.1 mM, 0.3 mM, 0.6 mM) (P<0.01, n=7). The amplitude of the oscillatory component reached its maximum at 0.3 mM heptanol (209.6 ± 19.6% of control; n=7). This rise in the amplitude could be due to the concomitant suppression of the tonic component on which the oscillations are superimposed (indicated by the black bar ( ) in Fig. 1) . In control contractions, the larger amplitude tonic component may "mask" the smaller amplitude oscillatory component. The total number of spikes in the oscillatory phase decreased monotonically with increasing heptanol concentration (Fig. 4) . Along with their number, the frequency of spikes was also reduced evenly in a concentration dependent manner. For example, frequency in the time span of 40-120 s was reduced from 0.44 ± 0.02 Hz in control to 0.32 ± 0.02 Hz with 0.6 mM heptanol (P<0.01) and this was further reduced to 0.21 ± 0.01 Hz with 0.9 mM heptanol (P<0.01). The above results suggest that different components of NA-induced contractions vary in susceptibility to heptanol. As these contractions have also been shown to depend on different Ca 2+ sources Berridge, 1993; Zhong and Minnenan, 1999) , we explored the effect of nifedipine on NA-induced contractions to illuminate the possibility of an inter-relation between gap junction-dependent component and the Ca 2+ o mobilized via nifedipine-sensitive Ltype Ca 2+ channels.
Effect of nifedipine on NA-induced contractions
Nifedipine reduced the phasic component of the NA-induced contraction by 34.6 ± 4.1% (n=6), without affecting the latency of this phase. 2 μM nifedipine strongly inhibited the tonic component, by 89.5 ± 3.0% (n=6) (Figs. 5 and 6) and abolished the oscillatory component. This suggests that the nifedipine-sensitive fraction of the phasic component could be similar to the heptanol-sensitive fraction in terms of its mechanisms. To address this question, the combined actions of heptanol and nifedipine were investigated.
Effect of combined action of nifedipine and heptanol
The reduction in the phasic component of the NA-induced contraction due to the combined action of heptanol and nifedipine was significantly higher than the reduction due to either nifedipine or heptanol alone (P<0.01); 61.2 ± 8.4% by the combination as compared to ~35% by nifedipine alone and ~33% by heptanol alone (n=6, P<0.01) (Fig. 6 ). The latency of this phase remained unchanged. The combined action of both these agents reduced the tonic component by 94.5 ± 1.0% and the oscillatory component remained abolished (Figs. 6 and 5).
Discussion
In the present study we have attempted to address the role of cell-to-cell coupling in the genesis of adrenergic contractions in the smooth muscle of the rat vas deferens and to elucidate the interaction of this coupling with processes involving [Ca 2+ ]o. Although some studies have been conducted previously on the contribution of cell-to-cell coupling to agonist-induced contractions in a variety of smooth muscle organs (Christ, 1995; Christ et al., 1996; Matchkov et al., 2004) , in rat vas deferens the dynamics of recruitment of cells via different pathways, e.g. the Representative traces of the effect of 2 μM nifedipine and 2 μM nifedipine with 2 mM heptanol on contractions elicited by addition of 20 μM NA to the organ bath for 2 min. direct activation pathway and the intercellular communication pathways has not been subjected to close scrutiny. Here, we have concentrated on the initial phases of development of contraction (over a time course <2 min), which we felt would facilitate the analysis of the dynamics of cell recruitment. However, our period of observation is also adequate for the full development of the slower phases (tonic and oscillatory) of the contractions (Boselli et al., 1997) , which can therefore be analyzed in equal detail.
Role of cell-to-cell coupling in NA-induced contraction
Our observation that the different phases of the NA-induced contractions differed in their susceptibility to heptanol is of particular interest. We observed that even at the highest concentrations of heptanol used here (2 mM) the phasic component was only reduced (by about a third) but not abolished. The resistance of part of the phasic component leads us to believe that this component is largely generated by cells which are directly activated by NA. As the partially heptanol-sensitive phasic component develops over a relatively rapid time course compared with the overall contraction (e.g. over 10-20 sec), gap-junctional recruitment of cells appears to play a role relatively early in the development of contraction. Although 1-heptanol is a relatively selective gap junctional blocker, the compound has been reported to have other actions which could influence contractions (Keevil et al., 2000; Rozental et al., 2000; Squires et al., 2000; Yamamoto et al., 1998) . These non-specific actions, in particular direct or indirect block of voltage gated Ca 2+ channels (VGCCs), may account for part of the inhibition of the phasic component. However we find that in tissues pre-inhibited by L-type VGCC blocker nifedipine, heptanol further suppresses the phasic component, indicating a mechanism of action independent of VGCCs. Furthermore, the reduction observed with heptanol alone was not significantly different than that induced by heptanol in tissues preincubated with nifedipine (P>0.01), indicating involvement of similar mechanisms in the presence or absence of nifedipine. Heptanol has also been suggested to exert other non-junctional actions in various tissues (activation of KCa channels, reduction of [Ca 2+ ]i (Matchkov et al., 2004) ; voltage-dependent Na + current suppression (Nelson and Makielski, 1991) ; decreased voltage-dependent K + and Ca 2+ currents (Perez-Armendariz et al., 1991) ). However, in a recent detailed characterization of its effects on vascular smooth muscle cells (Matchkov et al., 2004) , it was shown that heptanol, over the range of concentrations used in our study (0.5-2.0 mM), potently increased the input resistance of the cells and desynchronized their [Ca 2+ ]i oscillations, indicating that it powerfully uncoupled the cells. Indeed, in several recent studies carried out on a range of cell / tissue preparations, including mouse heart (Knapp et al., 2005) , rabbit heart (Przyklenk et al., 2005) , bovine oocytes (Atef et al., 2005) , ciliary body (Do et al., 2004) , and human HeLa cells (Bader and Weingart, 2004) , heptanol has been either shown (Knapp et al., 2005; Atef et al., 2005) or assumed (Do et al., 2004; Bader and Weingart, 2004) to act as a specific gap junction blocker over a range of concentrations (≤ 10 mM), substantially larger than those used in our study (≤ 2 mM). In our own studies on mammalian vas deferens, the concentrations of heptanol employed to study the effects of uncoupling have not been found to affect resting potential (guinea-pig vas deferens: Manchanda and Venkateswarlu, 1997 ; rat vas deferens: Palani and Manchanda, unpublished observations), indicating a lack of effect on membrane ion channels. Additional evidence for the absence of non-specific actions of heptanol on ion channels comes from our observations in guinea-pig vas deferens (Palani and Manchanda, unpublished observations) that 2 mM heptanol did not affect the depolarizations produced by exogenous application of NA, which are known to be induced by PKC-pathway mediated inhibition of K channels, via activation of α1-adrenoceptor (Kamimura et al., 2000) , thus indicating that heptanol also leaves PKC-pathway unaffected.
In view of the above, the drastic reduction (by ~ 96%) of the tonic component in the presence of heptanol (2 mM) would suggest that this phase is predominantly dependent on gap junctional communication rather than the direct action of NA as seen for the phasic component. It is conceivable that, as time proceeds, diffusion of NA within the tissue and the resulting direct action of NA on deeper layer of cells may still produce a tonic component outside our period of observation (2 min) of comparable magnitude to the control contractions. This is supported by the slower rate of development and continued rise of the tonic component in the presence of heptanol (Fig. 3) . However, the further development of this contraction cannot not be predicted with confidence since it would be modulated by the diffusion rate and neuronal uptake of NA along with the ongoing desensitization of α1 receptors (Chalothron et al., 2002; Ferguson, 2001; García-Sáinz et al., 2000; Kenakin, 1980; Schomig et al., 1991) . The oscillatory contractions are the least investigated aspect of the NA-induced contractions to date. We observe that at low heptanol concentrations the amplitude of the spikes in the oscillatory components increases while their frequency and number decreases along with the suppression of the tonic component, indicating a desynchronization of the contraction. Thus, gap junctional communication may influence not only the speed of force development and its amplitude, but also its synchronization (see also, Ohara, 2002; Margineanu and Klitgaard, 2001) .
In this respect it is interesting that heptanol has been reported to desynchronize Ca 2+ i oscillations in smooth muscle cells in various organs (Sell et al., 2002; Squires et al., 2000; Watts and Webb, 1996; Yao et al., 2002) . The effect of heptanol on neurogenic contractions in the guinea pig vas deferens reported earlier (Venkateswarlu et al., 1999) and on NA-induced contractions in rat vas deferens in this study lends further support to the role of gap junctions in the coordinated contractions of this organ.
Interdependence of Ca 2+ -mediated and gap junction mediated components
In rat vas deferens, several reports have shown that in exogenous NA-induced contractions the phasic component is dependent on intracellular Ca 2+ and the tonic component on extracellular Ca 2+ (Dolphin, 2003; Vesperinas et al., 1989; Zhong and Minnenan, 1999 components. In such a scenario, nifedipine (2 μM) and heptanol (2 mM) would elicit similar patterns of effects, a prediction supported by our observations (Fig. 6 ).
In conclusion, based on the premise that heptanol selectively blocks gap junctional cell-tocell communication in smooth muscles, a large part (> 90%) of tonic and oscillatory contractions, and a smaller part (~ 40%) of phasic contraction, appear to be mediated by gap-junction based coupling, which also seems to play a crucial role in co-ordinating the tonic contraction. Furthermore the recruitment of cells via gap junctions (e.g., for the tonic and oscillatory contractions) appears to be crucially dependent on Ca 2+ derived from extracellular sources via nifedipine-sensitive L-type Ca 2+ channels. This interplay between recruitment of cells by intercellular communication pathways and extracellular Ca 2+ would need to be elucidated in studies at the cellular level (e.g., Hennig et al., 2002; Nihei et al., 2003; Yao et al., 2002) and may shed new light on our understanding of smooth muscle contractility.
